Kalaari Capital
// PORTFOLIO INTELLIGENCE
// COMPANIES TRACKED
5
// PORTFOLIO VALUATION (TRACKED)
$22.1B
Combined current valuation of portfolio companies in WOWLS database — not fund AUM or capital deployed
// SECTORS COVERED
10
// THREAT LEVEL DISTRIBUTION
- DANGEROUS2 · 40%
- ARMED1 · 20%
- TERMINAL HYPE1 · 20%
- ZOMBIECORN1 · 20%
Based on 5 enriched portfolio companies
// FULL NETWORK ACCESS
Don't just track Kalaari Capital.
Master the entire 2,033-investor intelligence network.
Stop analyzing one fund at a time. Instantly filter every VC, angel investor, and corporate fund by sector, stage, and portfolio performance. Find every fund backing your specific market vertical. See which investors have the best and worst track records — ranked by WOWL hit rate and miss rate across 1,032 unicorn companies.
2,033 investors tracked · 1,032 portfolio companies assessed
Acquire Intel →// 5 TIERS · PAYPAL SECURED
// NOTABLE INVESTMENTS
// PORTFOLIO COMPANIES
5 companies · $22.1B combined valuation
| COMPANY | SECTOR | VALUATION | ROUND | YEAR | THREAT |
|---|---|---|---|---|---|
| Dream11 | fantasy sports | $8B | SEED | 2012 | DANGEROUS |
| Dream Sports | gaming | $8B | SERIES_A | 2014 | DANGEROUS |
| Upstox | brokerage | $3.4B | SERIES_A | 2016 | ARMED |
| CureFit | healthtech | $1.56B | SEED | 2016 | TERMINAL HYPE |
| ShopClues | ecommerce | $1.1B | SERIES_D | 2015 | ZOMBIECORN |
// RECENT ACTIVITY
// WOWL ASSESSMENT
Kalaari Capital is an India-focused early-stage VC betting on consumer internet and fintech plays in a market where regulatory risk moves faster than exit windows. The portfolio reveals a fund that picked winners in Dream Sports and Upstox but now carries the consequences of backing ShopClues through its slow death and CureFit through its hype cycle collapse. Their 40% hit rate demonstrates genuine pattern recognition in Indian consumer behavior, but the 40% miss rate and the absence of exits tells the real story: unicorn creation without liquidity realization.
Dream Sports at $8B validates the fund's ability to identify consumer internet winners in regulated spaces. Upstox demonstrates similar pattern recognition in fintech. But ShopClues at $1.1B as a ZOMBIECORN and CureFit's collapse from healthtech darling to TERMINAL HYPE case study reveal the downside: Kalaari can pick early but struggles when market conditions turn. Portfolio composition shows winner identification skills undermined by India's exit drought — no public companies, no meaningful acquisitions, just paper markups waiting for liquidity that may never come.
// THREAT LEVEL: ARMED
VERDICT: Pattern recognition works, exit execution does not — trapped holding Indian unicorns with no path to cash realization.
// WHY WOWLS WATCHES
The fund represents India VC's central contradiction: genuine skill at identifying category winners combined with structural inability to convert paper gains into distributed returns. Every portfolio success story is simultaneously a liquidity prisoner.
// SIMILAR FUNDS
// PACK DEBATE
// PACK DEBATE — be the first to weigh in
Google account required — no spam, no nonsense
// LOADING INTEL…
// INTELLIGENCE PENDING
// INTELLIGENCE DISCLAIMER: Fund assessments represent editorial opinion based on publicly available data. Portfolio coverage reflects companies tracked in the WOWLS database and may not represent complete investment history. Hit and miss rates are calculated from tracked portfolio companies only. Not financial or investment advice.
// ENGAGE THE FULL ARSENAL
Done reading on Kalaari Capital?
Unlock the entire 1,032-company hitlist and 2,033 investor contacts.
Full portfolio breakdowns. Founder dossiers. VC outreach data. Threat level intel updated continuously.
→ Deploy 5-Tier Order Form// ARBAN · ZUUN · MINGHAN · TUMEN · KHAN